Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Revenue
Orthopedic product sales	$ 58,194,249	$ 34,569,160
Other revenue	1,151,468	762,652
Total Revenue	59,345,717	35,331,812
Cost of Sales	20,262,728	13,034,314
Gross Profit	39,082,989	22,297,498
Operating Expenses
General and administrative	12,993,307	8,886,972
Sales and marketing	28,731,184	16,912,865
Research and development	2,546,362	1,443,018
Depreciation and amortization	3,819,588	271,748
Acquisition and integration related expenses (Note 2)	4,935,755	0
Extinguishment of debt	(2,345,019)	0
Impairment of assets	233,748	912,549
Non-cash consulting expense	246,165	135,075
Total Operating Expenses	51,161,090	28,562,227
Loss from Operations	(12,078,101)	(6,264,729)
Other Income (Expense)
Interest expense	(7,733,748)	(5,660,357)
Change in warrant derivative liability	270,020	1,736,053
Non-cash consideration associated stock agreement	(558,185)	0
Other income (expense)	388,176	(318,836)
Total Other Income (Expense)	(7,633,737)	(4,243,140)
Net Loss from Operations Before Benefit (Provision) for Income Taxes	(19,711,838)	(10,507,869)
Benefit (Provision) for Income Taxes
Current	0	0
Deferred	17,537,408	0
Net Loss	$ (2,174,430)	$ (10,507,869)
Net loss per share:
Basic	$ (0.24)	$ (1.76)
Dilutive	$ (0.24)	$ (1.76)
Shares used in the computation:
Basic	9,055,483	5,954,195
Dilutive	9,055,483	5,954,195